278 Phase I clinical trial evaluating the safety of ADP-A2M10 SPEAR T-cells in patients with MAGE-A10+ advanced non-small cell lung cancer
George Blumenschein, Siddhartha Devarakonda, Melissa Johnson, Victor Moreno, Justin Gainor, Martin Edelman, John Heymach, Ramaswamy Govindan, Carlos Bachier, Bernard Doger de Spéville, Matthew Frigault, Anthony Olszanski, Vincent Lam, Natalie Hyland, Jean-Marc Navenot, Svetlana Fayngerts, Jane Bai, Elliot Norry, Paula Fracasso
Journal for ImmunoTherapy of Cancer Nov 2020, 8 (Suppl 3) A169-A170; DOI: 10.1136/jitc-2020-SITC2020.0278